Julia Novak

Chief Tech/Sci/R&D Officer at Blaze Bioscience, Inc.

Health Services

Consumer Services

Health Technology

Profile

Julia Novak is currently the Vice President-Research at Blaze Bioscience, Inc. Previously, she worked as the Director-Portfolio & Project Management at ZymoGenetics, Inc. She obtained her undergraduate and doctorate degrees from the University of Houston.

Julia Novak active positions

Companies	Position	Start
Blaze Bioscience, Inc. Blaze Bioscience, Inc. Medical/Nursing ServicesHealth Services Blaze Bioscience, Inc. develops tumor paint products and Optide-based guided therapeutics for cancer patients. The firm provides BLZ-100. The company was founded by James M. Olson in 2010 and is headquartered in Seattle, WA.	Chief Tech/Sci/R&D Officer	-

All active positions of Julia Novak

Former positions of Julia Novak

Companies	Position	End
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Corporate Officer/Principal	-

See the detail of Julia Novak's experience

Training of Julia Novak

University of Houston

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Julia Novak's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Blaze Bioscience, Inc. Blaze Bioscience, Inc. Medical/Nursing ServicesHealth Services Blaze Bioscience, Inc. develops tumor paint products and Optide-based guided therapeutics for cancer patients. The firm provides BLZ-100. The company was founded by James M. Olson in 2010 and is headquartered in Seattle, WA.	Health Services
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology